Among 361 pediatric AML patients who had been examined by using molecular biology technique, 19% of the patients showed positive AML1/ETO fusion gene, 18% of the patients showed positive PML/RAR? fusion gene, while 4.2% of patients showed positive CBF?/MYH11. 